Pilocytic astrocytoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251612C71.9
Who is this for?
Show terms as
1FDA treatments19Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pilocytic astrocytoma (PA), also known as juvenile pilocytic astrocytoma or cystic cerebellar astrocytoma, is a slow-growing (WHO grade I) brain tumor that arises from astrocytes, a type of glial cell in the central nervous system. It is the most common brain tumor in children, typically occurring in the cerebellum (posterior fossa), but can also develop in the optic pathways, hypothalamus, brainstem, and cerebral hemispheres. The tumor is generally well-circumscribed and often contains both solid and cystic components. Pilocytic astrocytomas are characterized histologically by biphasic architecture with compact bipolar (piloid) cells and loose-textured multipolar cells, along with Rosenthal fibers and eosinophilic granular bodies. Symptoms depend on the tumor's location and size. Cerebellar tumors commonly present with headaches, nausea, vomiting, balance difficulties (ataxia), and signs of increased intracranial pressure due to obstructive hydrocephalus. Optic pathway tumors may cause visual disturbances, proptosis, or hormonal abnormalities when the hypothalamus is involved. Pilocytic astrocytomas are frequently associated with neurofibromatosis type 1 (NF1), particularly optic pathway gliomas. The BRAF-KIAA1549 fusion gene is the most common molecular alteration found in sporadic cases, resulting in activation of the MAPK/ERK signaling pathway. The primary treatment is surgical resection, which is often curative when gross total removal is achieved, with excellent long-term survival rates exceeding 90% at 10 years. When complete resection is not feasible due to tumor location (e.g., hypothalamic or brainstem tumors), chemotherapy and/or radiation therapy may be employed. Targeted therapies, including MEK inhibitors and BRAF inhibitors, have shown promise in recurrent or progressive cases, particularly those harboring BRAF alterations. Overall, pilocytic astrocytoma carries one of the most favorable prognoses among all central nervous system tumors.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

1 available

Ojemda

tovorafenib· Day One Biopharmaceuticals, Inc.Orphan Drug

Treatment of pediatric patients 6 months of age and older and young adults with relapsed or refractory pediatric low-grade glioma (pLGG) harboring a BRAF fusion or rearrangement.

No actively recruiting trials found for Pilocytic astrocytoma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pilocytic astrocytoma community →

Specialists

19 foundView all specialists →
SP
Stanislaw R. Burzynski, MD, PhD
HOUSTON, TX
Specialist
PI on 29 active trials
GM
Giles W. Robinson, MD
MEMPHIS, TN
Specialist
PI on 4 active trials1 Pilocytic astrocytoma publication
JM
Julie Krystal, MD
NEW HYDE PARK, NY
Specialist
PI on 1 active trial
EM
Ernest C. Borden, MD
Specialist
PI on 5 active trials
PM
Patrick Wen, MD
BOSTON, MA
Specialist
PI on 6 active trials
TM
Timothy F. Cloughesy, MD
LOS ANGELES, CA
Specialist
PI on 4 active trials
SM
Shivaani Kummar, MD
PORTLAND, OR
Specialist
PI on 5 active trials
JM
Jana Portnow, MD
DUARTE, CA
Specialist
PI on 3 active trials
DM
Dolly Aguilera, MD
ATLANTA, GA
Specialist
PI on 1 active trial
AO
Antonio Omuro
STANFORD, CA
Specialist
PI on 1 active trial
WP
Wenyin Shi, MD, PhD
PHILADELPHIA, PA
Specialist
PI on 5 active trials
SM
Scot C. Remick, MD
SCARBOROUGH, ME
Specialist
PI on 9 active trials
PM
Patrick A. Thompson, MD
Specialist
PI on 2 active trials
JM
John Suh, MD
Specialist
PI on 1 active trial
SP
Sarah J. Nelson, PhD
Specialist
PI on 1 active trial
EM
Edward G. Shaw, MD
Specialist
PI on 4 active trials
AM
Anna Vinitsky, MD, MS
MEMPHIS, TN
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pilocytic astrocytoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pilocytic astrocytomaForum →

No community posts yet. Be the first to share your experience with Pilocytic astrocytoma.

Start the conversation →

Latest news about Pilocytic astrocytoma

No recent news articles for Pilocytic astrocytoma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pilocytic astrocytoma

What is Pilocytic astrocytoma?

Pilocytic astrocytoma (PA), also known as juvenile pilocytic astrocytoma or cystic cerebellar astrocytoma, is a slow-growing (WHO grade I) brain tumor that arises from astrocytes, a type of glial cell in the central nervous system. It is the most common brain tumor in children, typically occurring in the cerebellum (posterior fossa), but can also develop in the optic pathways, hypothalamus, brainstem, and cerebral hemispheres. The tumor is generally well-circumscribed and often contains both solid and cystic components. Pilocytic astrocytomas are characterized histologically by biphasic archit

How is Pilocytic astrocytoma inherited?

Pilocytic astrocytoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pilocytic astrocytoma typically begin?

Typical onset of Pilocytic astrocytoma is childhood. Age of onset can vary across affected individuals.

Which specialists treat Pilocytic astrocytoma?

19 specialists and care centers treating Pilocytic astrocytoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.